Litcius/Paper detail

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Jordi Remón, Francesco Passiglia, Myung‐Ju Ahn, Fabrice Barlési, Patrick M. Forde, Edward B. Garon, Scott Gettinger, Sarah B. Goldberg, Roy S. Herbst, Leora Horn, Kaoru Kubota, Shun Lü, Laura Mezquita, Luis Paz‐Ares, Sanjay Popat, Kurt A. Schalper, Ferdinandos Skoulidis, Martin Reck, Alex A. Adjei, Giorgio V. Scagliotti

2020Journal of Thoracic Oncology183 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunotherapyOncologyImmune systemMesotheliomaClinical trialImmunologyInternal medicinePathologyCancer Immunotherapy and BiomarkersNeuroblastoma Research and TreatmentsOccupational and environmental lung diseases
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations | Litcius